Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

SW Lam; N M Nota; Agnes Jager; MMEM Bos; J van den Bosch; AMT van der Velden; JEA Portielje; AH Honkoop; H van Tinteren; Eva Boven

doi:10.1158/1078-0432.CCR-15-1005

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

SW Lam, N M Nota, Agnes Jager, MMEM Bos, J van den Bosch, AMT van der Velden, JEA Portielje, AH Honkoop, H van Tinteren, Eva Boven

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	English
Pages (from-to)	1611-1620
Number of pages	10
Journal	Clinical Cancer Research
Volume	22
Issue number	7
DOIs	https://doi.org/10.1158/1078-0432.CCR-15-1005
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-15-1005

http://hdl.handle.net/1765/88264

Cite this

Lam, SW., Nota, N. M., Jager, A., Bos, MMEM., van den Bosch, J., van der Velden, AMT., Portielje, JEA., Honkoop, AH., van Tinteren, H., & Boven, E. (2016). Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy. Clinical Cancer Research, 22(7), 1611-1620. https://doi.org/10.1158/1078-0432.CCR-15-1005

@article{5bcc3ff2db3e46348b94625b882d63d0,

title = "Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy",

author = "SW Lam and Nota, {N M} and Agnes Jager and MMEM Bos and {van den Bosch}, J and {van der Velden}, AMT and JEA Portielje and AH Honkoop and {van Tinteren}, H and Eva Boven",

year = "2016",

doi = "10.1158/1078-0432.CCR-15-1005",

language = "English",

volume = "22",

pages = "1611--1620",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

Lam, SW, Nota, NM, Jager, A, Bos, MMEM, van den Bosch, J, van der Velden, AMT, Portielje, JEA, Honkoop, AH, van Tinteren, H & Boven, E 2016, 'Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy', Clinical Cancer Research, vol. 22, no. 7, pp. 1611-1620. https://doi.org/10.1158/1078-0432.CCR-15-1005

TY - JOUR

T1 - Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

AU - Lam, SW

AU - Nota, N M

AU - Jager, Agnes

AU - Bos, MMEM

AU - van den Bosch, J

AU - van der Velden, AMT

AU - Portielje, JEA

AU - Honkoop, AH

AU - van Tinteren, H

AU - Boven, Eva

PY - 2016

Y1 - 2016

U2 - 10.1158/1078-0432.CCR-15-1005

DO - 10.1158/1078-0432.CCR-15-1005

M3 - Article

SN - 1078-0432

VL - 22

SP - 1611

EP - 1620

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 7

ER -